Clinical
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
2
AES Presentations Highlight Zorevunersen as Disease-Modifying Treatment for Dravet Syndrome
3
Open Label Extension Confirms Cenobamate's Efficacy in Asian Populations
4
Lacosamide Displays Positive Efficacy and Safety in Phase 2 Clinical Trial of Neonatal Seizures
5
